BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19169914)

  • 41. [Primary sclerosing cholangitis: association with Crohn disease and colonic cancer].
    Brixen K; Jacobsen NO; Hermansen K
    Ugeskr Laeger; 1988 Apr; 150(17):1047-8. PubMed ID: 3376239
    [No Abstract]   [Full Text] [Related]  

  • 42. Late colonic stent perforation following chemotherapy.
    Verburg RJ; Meijssen MA
    Endoscopy; 2009; 41 Suppl 2():E248. PubMed ID: 19787574
    [No Abstract]   [Full Text] [Related]  

  • 43. Colon cancer in a 16-year-old girl: signet-ring cell carcinoma without microsatellite instability--an unusual suspect.
    Jain AK; Motil KJ; Olutoye OO; Cope-Yokoyama S; Egler RA; Tatevian N
    J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):110-4. PubMed ID: 19172134
    [No Abstract]   [Full Text] [Related]  

  • 44. [Position of adjuvant and palliative chemotherapy in colonic cancer treatment].
    Louvet C
    Gastroenterol Clin Biol; 1998 Mar; 22(3 Suppl):S255-64. PubMed ID: 9762262
    [No Abstract]   [Full Text] [Related]  

  • 45. Older age--not a barrier to cancer treatment.
    Muss HB
    N Engl J Med; 2001 Oct; 345(15):1128-9. PubMed ID: 11596595
    [No Abstract]   [Full Text] [Related]  

  • 46. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral signs of intravenous chemotherapy with 5-Fluorouracil and Leucovorin calcium in colon cancer treatment.
    Mazzeo MA; Linares JA; Campos ML; Busamia BE; Dubersarsky C; Lavarda M; Jarchum G; Finkelberg AB
    Med Oral Patol Oral Cir Bucal; 2009 Mar; 14(3):E108-13. PubMed ID: 19242388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical observation on treatment of colonic cancer with combined treatment of chemotherapy and Chinese herbal medicine.
    Zhou LY; Shan ZZ; You JL
    Chin J Integr Med; 2009 Apr; 15(2):107-11. PubMed ID: 19407947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The current status of adjuvant chemotherapy of colonic cancer].
    Takiuchi H
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1826-8. PubMed ID: 19999632
    [No Abstract]   [Full Text] [Related]  

  • 51. [Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case].
    Takahashi T; Kochi M; Kanamori N; Kaiga T; Funada T; Fujii M; Takayama T
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1885-8. PubMed ID: 19920393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of metastatic colon cancer by molecular targeting drugs].
    Sakamoto T; Machida N; Boku S
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1854-62. PubMed ID: 19058425
    [No Abstract]   [Full Text] [Related]  

  • 53. Factors that affect the duration of the interval between the completion of palliative chemotherapy and death.
    Hashimoto K; Yonemori K; Katsumata N; Hotchi M; Kouno T; Shimizu C; Tamura K; Ando M; Takeuchi M; Fujiwara Y
    Oncologist; 2009 Jul; 14(7):752-9. PubMed ID: 19596665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
    Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
    J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Update: NCCN colon cancer Clinical Practice Guidelines.
    Engstrom P
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S25-8. PubMed ID: 16280108
    [No Abstract]   [Full Text] [Related]  

  • 56. Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity.
    Milla P; Airoldi M; Weber G; Drescher A; Jaehde U; Cattel L
    Anticancer Drugs; 2009 Jun; 20(5):396-402. PubMed ID: 19287306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal assessment of quality of life in rectal cancer patients with or without stomas following primary resection.
    Yau T; Watkins D; Cunningham D; Barbachano Y; Chau I; Chong G
    Dis Colon Rectum; 2009 Apr; 52(4):669-77. PubMed ID: 19404073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone marrow necrosis caused by metastatic colon cancer.
    Wang YC; Chang PY; Yao NS
    J Clin Oncol; 2009 Aug; 27(23):e48. PubMed ID: 19470920
    [No Abstract]   [Full Text] [Related]  

  • 59. Chemotherapy in patients with penile carcinoma.
    Protzel C; Hakenberg OW
    Urol Int; 2009; 82(1):1-7. PubMed ID: 19172088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary sclerosing cholangitis lesions in a patient with Crohn's disease and HCV infection.
    Goritsas C; Papadopoulos N; Trigidou R; Tzathas H
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):222-3. PubMed ID: 17592575
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.